|
US20030181488A1
(en)
|
2002-03-07 |
2003-09-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
|
|
US20050070537A1
(en)
|
2002-10-10 |
2005-03-31 |
Chris Rundfeldt |
Use of dihydroimidazolones for the treatment of dogs
|
|
DE10337697A1
(de)
*
|
2003-08-16 |
2005-03-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Tablette enthaltend 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenyl-amino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester oder dessen Salze
|
|
DE10339862A1
(de)
*
|
2003-08-29 |
2005-03-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)- phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester-Methansulfonat und dessen Verwendung als Arzneimittel
|
|
DE10341043A1
(de)
*
|
2003-09-03 |
2005-03-31 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue oral zu applizierende Darreichungsform für 3-[(2-{[4-Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester und dessen Salze
|
|
US20070298095A1
(en)
*
|
2004-05-24 |
2007-12-27 |
Shionogi Qualicaps Co., Ltd. |
Surface-Modified and Solubility-Improved Hard Capsule
|
|
DE102004062864A1
(de)
|
2004-12-21 |
2006-06-22 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Folienbehälter
|
|
US20060222640A1
(en)
*
|
2005-03-29 |
2006-10-05 |
Boehringer Ingelheim International Gmbh |
New pharmaceutical compositions for treatment of thrombosis
|
|
DE102005025728A1
(de)
|
2005-06-04 |
2006-12-07 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Polymorphe von 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-Propionsäure-ethylester
|
|
DE102005061623A1
(de)
*
|
2005-12-21 |
2007-06-28 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verbessertes Verfahren zur Herstellung von 4-(Benzimidazolylmethylamino)-Benzamidinen und deren Salzen
|
|
DE102005061624A1
(de)
*
|
2005-12-21 |
2007-06-28 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verbessertes Verfahren zur Herstellung von Salzen von 4-(Benzimidazolylmethylamino)-Benzamidinen
|
|
AU2007276205A1
(en)
*
|
2006-07-17 |
2008-01-24 |
Boehringer Ingelheim International Gmbh |
New indications for direct thrombin inhibitors in the cardiovascular field
|
|
WO2008009640A1
(en)
*
|
2006-07-17 |
2008-01-24 |
Boehringer Ingelheim International Gmbh |
New paediatric indications for direct thrombin inhibitors
|
|
US20100087488A1
(en)
*
|
2006-10-10 |
2010-04-08 |
Boehringer Ingelheim International Gmgh |
Physiologically Acceptable Salts of 3-[(2--1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester
|
|
CA2716642C
(en)
*
|
2008-03-28 |
2017-02-28 |
Boehringer Ingelheim International Gmbh |
Method for manufacturing acid pellets
|
|
RU2010143901A
(ru)
*
|
2008-03-28 |
2012-05-10 |
Бёрингер Ингельхайм Интернациональ Гмбх (De) |
Способ получения композиций дабигатрана для перорального введения
|
|
RU2529798C2
(ru)
*
|
2008-07-14 |
2014-09-27 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Способ получения лекарственных соединений, содержащих дабигатран
|
|
NZ602592A
(en)
|
2008-07-28 |
2014-01-31 |
Takeda Pharmaceutical |
Light irradiation resistant pharmaceutical composition
|
|
BRPI0917507A2
(pt)
*
|
2008-08-19 |
2015-11-17 |
Boehring Ingelheim Internat Gmbh |
dabigatrana para a caterização cardíaca percutânea intervencionista
|
|
US20110190352A1
(en)
*
|
2008-08-19 |
2011-08-04 |
Boehringer Ingelheim International Gmbh |
Use of dabigatranetexilate for treating patients with pulmonary hypertension
|
|
EP2429520A1
(en)
|
2009-05-14 |
2012-03-21 |
Boehringer Ingelheim International GmbH |
New combination therapy in treatment of oncological and fibrotic diseases
|
|
NZ597359A
(en)
|
2009-08-24 |
2014-01-31 |
Boehringer Ingelheim Int |
Emergency interventions of active charcoal with dabigatran etexilate overdosing
|
|
EA201201202A1
(ru)
|
2010-03-01 |
2013-04-30 |
Рациофарм Гмбх |
Пероральная фармацевтическая композиция, содержащая этексилат дабигатрана
|
|
CA2792273A1
(en)
|
2010-03-08 |
2011-09-15 |
Ratiopharm Gmbh |
Dabigatran etexilate-containing pharmaceutical composition
|
|
US20130177652A1
(en)
|
2010-07-01 |
2013-07-11 |
Krka, Tovarna Zdravil, D.D., Novo Mesto |
Pharmaceutical oral dosage forms comprising dabigatran etexilate and its pharmaceutically acceptable salts
|
|
WO2012004397A1
(en)
|
2010-07-09 |
2012-01-12 |
Esteve Química, S.A. |
Intermediates and process for preparing a thrombin specific inhibitor
|
|
EP2937343A1
(en)
|
2010-07-09 |
2015-10-28 |
Esteve Química, S.A. |
Process of preparing a thrombin specific inhibitor
|
|
ES2550771T3
(es)
|
2010-09-27 |
2015-11-12 |
Ratiopharm Gmbh |
Sal de bismesilato etexilato de dabigatrán, formas en estado sólido y proceso para la preparación de las mismas
|
|
US20120301541A1
(en)
*
|
2011-05-24 |
2012-11-29 |
Haronsky Elina |
Compressed core for pharmaceutical composition
|
|
CN102391250B
(zh)
*
|
2011-08-29 |
2013-06-19 |
石药集团欧意药业有限公司 |
一种达比加群酯化合物、制备方法及其药物组合物
|
|
EP2793864A1
(en)
|
2011-12-22 |
2014-10-29 |
Boehringer Ingelheim International GmbH |
Immediate release multi unit pellet system
|
|
US9212166B2
(en)
|
2012-01-20 |
2015-12-15 |
Cadila Healthcare Limited |
Process for the preparation of dabigatran etexilate mesylate and polymorphs of intermediates thereof
|
|
WO2013110567A1
(en)
|
2012-01-24 |
2013-08-01 |
Boehringer Ingelheim International Gmbh |
Novel orally administered dabigatran formulation
|
|
PT2817000T
(pt)
|
2012-02-21 |
2021-11-02 |
Towa Pharmaceutical Europe S L |
Composições farmacêuticas de dabigatrano etexilato
|
|
EP2631234A1
(en)
|
2012-02-23 |
2013-08-28 |
Esteve Química, S.A. |
Solid forms of dabigatran etexilate mesylate and processes for their preparation
|
|
WO2013144971A1
(en)
|
2012-03-27 |
2013-10-03 |
Cadila Healthcare Limited |
New solid forms of dabigatran etexilate bisulfate and mesylate and processes to prepare them
|
|
EP2834224B1
(en)
|
2012-04-02 |
2018-06-06 |
MSN Laboratories Limited |
Process for the preparation of benzimidazole derivatives and salts thereof
|
|
US20130345262A1
(en)
|
2012-06-25 |
2013-12-26 |
Boehringer Ingelheim International Gmbh |
Method for prevention of stroke
|
|
CA2886094A1
(en)
|
2012-09-28 |
2014-04-03 |
Ranbaxy Laboratories Limited |
Process for the preparation of dabigatran etexilate or pharmaceutically acceptable salt thereof
|
|
US20150246899A1
(en)
|
2012-09-28 |
2015-09-03 |
Ranbaxy Laboratories Limited |
Process for the preparation of dabigatran etexilate or pharmaceutically acceptable salt thereof
|
|
EP2722033A1
(en)
|
2012-10-19 |
2014-04-23 |
Sanovel Ilac Sanayi ve Ticaret A.S. |
Pharmaceutical Compositions of Dabigatran Free Base
|
|
EP2722034B1
(en)
|
2012-10-19 |
2020-09-16 |
Sanovel Ilac Sanayi ve Ticaret A.S. |
Oral pharmaceutical formulations comprising dabigatran
|
|
EP2740471B1
(en)
|
2012-12-07 |
2015-05-27 |
Hexal AG |
Oral pharmaceutical composition comprising dabigatran etexilate
|
|
CN103127109B
(zh)
*
|
2013-02-05 |
2014-08-13 |
南京华威医药科技开发有限公司 |
含达比加群酯或其盐和水合物的药用组合
|
|
EP2835370A1
(en)
|
2013-08-08 |
2015-02-11 |
Medichem, S.A. |
New crystals of dabigatran etexilate mesylate
|
|
CN104414995A
(zh)
*
|
2013-09-04 |
2015-03-18 |
天津汉瑞药业有限公司 |
甲磺酸达比加群酯的药用组合物
|
|
EP2853260A1
(en)
|
2013-09-27 |
2015-04-01 |
ratiopharm GmbH |
Pharmaceutical preparation comprising dabigatran etexilate bismesylate
|
|
US9820988B2
(en)
|
2014-03-24 |
2017-11-21 |
Boehringer Ingelheim Vetmedica Gmbh |
Treatment of epileptic disorders in feline animals
|
|
IN2014MU01042A
(enExample)
|
2014-03-26 |
2015-10-02 |
Cadila Healthcare Ltd |
|
|
EP2929884A1
(en)
|
2014-04-11 |
2015-10-14 |
Sanovel Ilac Sanayi ve Ticaret A.S. |
Pharmaceutical combinations of dabigatran and h2-receptor antagonists
|
|
WO2015155281A1
(en)
|
2014-04-11 |
2015-10-15 |
Sanovel Ilac Sanayi Ve Ticaret A.S. |
Pharmaceutical combinations of dabigatran and proton pump inhibitors
|
|
DE102014108210A1
(de)
|
2014-06-11 |
2015-12-17 |
Dietrich Gulba |
Rodentizid
|
|
US10675276B2
(en)
|
2014-11-03 |
2020-06-09 |
Hangzhou Solipharma Co., Ltd. |
Dosing preparation of dabigatran etexilate or a salt thereof and a preparation method thereof
|
|
CN105640909B
(zh)
*
|
2014-11-14 |
2019-09-20 |
正大天晴药业集团股份有限公司 |
一种含有达比加群酯的药用组合物
|
|
CN106924256B
(zh)
*
|
2015-12-25 |
2022-08-19 |
深圳市药欣生物科技有限公司 |
药物组合物及其制备方法
|
|
WO2016107605A1
(zh)
|
2014-12-31 |
2016-07-07 |
昆明积大制药股份有限公司 |
药物组合物及其制备方法
|
|
CN105797162B
(zh)
*
|
2014-12-31 |
2022-10-25 |
昆明积大制药股份有限公司 |
药用辅料表面改性方法
|
|
TR201502223A2
(tr)
|
2015-02-25 |
2016-09-21 |
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
Dronedaron ve dabigatranın farmasötik kombinasyonları.
|
|
CN106999434B
(zh)
*
|
2015-04-08 |
2020-05-22 |
杭州领业医药科技有限公司 |
一种含半胱氨酸盐酸盐的微丸及其制备方法
|
|
WO2017013106A1
(en)
|
2015-07-20 |
2017-01-26 |
Sanovel Ilac Sanayi Ve Ticaret A.S. |
Pharmaceutical formulations of dabigatran free base
|
|
CN105919962B
(zh)
*
|
2015-12-18 |
2019-01-18 |
重庆两江药物研发中心有限公司 |
一种达比加群酯片剂及其制备方法
|
|
WO2017111637A1
(en)
|
2015-12-23 |
2017-06-29 |
Zaklady Farmaceutyczne Polpharma Sa |
Pharmaceutical composition comprising dabigatran or a pharmaceutically acceptable salt thereof
|
|
EP3184102A1
(en)
|
2015-12-23 |
2017-06-28 |
Hexal AG |
Pharmaceutical composition of vortioxetine hydrobromide comprising an inert core formed of an acidic reacting compound
|
|
US10449195B2
(en)
|
2016-03-29 |
2019-10-22 |
Shenzhen Pharmacin Co., Ltd. |
Pharmaceutical formulation of palbociclib and a preparation method thereof
|
|
TR201606697A2
(tr)
|
2016-05-20 |
2017-12-21 |
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
Dabi̇gatranin yeni̇ oral farmasöti̇k formülasyonlari
|
|
EP3332771A1
(en)
|
2016-12-07 |
2018-06-13 |
Sanovel Ilac Sanayi ve Ticaret A.S. |
Multilayered tablet compositions of dabigatran
|
|
TR201617984A2
(tr)
|
2016-12-07 |
2018-06-21 |
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
Dabi̇gatranin farmasöti̇k kompozi̇syonlari
|
|
WO2018122262A1
(en)
|
2016-12-28 |
2018-07-05 |
Sanovel Ilac Sanayi Ve Ticaret A.S. |
Bilayer tablet formulations of dabigatran etexilate
|
|
JP2018184375A
(ja)
|
2017-04-27 |
2018-11-22 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ダビガトランエテキシラート又は医薬的に許容されるその塩を含む錠剤及びその製造方法
|
|
WO2018229784A1
(en)
*
|
2017-06-14 |
2018-12-20 |
Natco Pharma Limited |
Pharmaceutical compositions of dabigatran
|
|
CN109125274A
(zh)
*
|
2017-06-28 |
2019-01-04 |
上海美悦生物科技发展有限公司 |
注射用苯并咪唑类药用酸组合物及其制备方法和用途
|
|
TR201722186A2
(tr)
|
2017-12-27 |
2019-07-22 |
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
Dabi̇gatranin farmasöti̇k kompozi̇syonlari
|
|
TR201722323A2
(tr)
|
2017-12-27 |
2019-07-22 |
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
Dabi̇gatranin oral farmasöti̇k kompozi̇syonlari
|
|
TR201722353A2
(tr)
|
2017-12-27 |
2019-07-22 |
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
Dabi̇gatran eteksi̇lat i̇çeren oral uygulama i̇çi̇n farmasöti̇k formülasyon
|
|
TR201722630A2
(enExample)
|
2017-12-28 |
2019-07-22 |
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
|
|
CN110339193B
(zh)
|
2018-04-04 |
2022-04-29 |
上海汉都医药科技有限公司 |
含达比加群酯的药物组合物及其制备方法
|
|
KR20200082641A
(ko)
|
2018-12-31 |
2020-07-08 |
주식회사 유영제약 |
다비가트란 에텍실레이트를 포함하는 약제학적 조성물
|
|
EP3771465A1
(en)
|
2019-08-01 |
2021-02-03 |
Zaklady Farmaceutyczne Polpharma SA |
Pharmaceutical composition comprising dabigatran etexilate
|
|
KR20210157691A
(ko)
|
2020-06-22 |
2021-12-29 |
한국유나이티드제약 주식회사 |
다비가트란 에텍실레이트를 포함하는 경구용 약학조성물
|
|
KR20210157692A
(ko)
|
2020-06-22 |
2021-12-29 |
한국유나이티드제약 주식회사 |
다비가트란 에텍실레이트를 포함하는 경구용 약학조성물
|
|
KR20210157693A
(ko)
|
2020-06-22 |
2021-12-29 |
한국유나이티드제약 주식회사 |
다비가트란 에텍실레이트를 포함하는 경구용 약학조성물
|
|
CN114306245A
(zh)
|
2020-09-29 |
2022-04-12 |
深圳市药欣生物科技有限公司 |
无定形固体分散体的药物组合物及其制备方法
|
|
EP4070658A1
(de)
|
2021-04-06 |
2022-10-12 |
BIORoxx GmbH |
Verwendung von blutgerinnungshemmenden verbindungen als rodentizide
|
|
CN115227663B
(zh)
*
|
2021-04-22 |
2023-12-12 |
石药集团恩必普药业有限公司 |
一种甲磺酸达比加群酯胶囊及其制备方法
|
|
BR112023025430A2
(pt)
*
|
2021-06-04 |
2024-02-20 |
Zim Laboratories Ltd |
Composições farmacêuticas inovadoras que compreendem etexilato de dabigatrana ou sal do mesmo
|
|
WO2023139243A1
(en)
|
2022-01-21 |
2023-07-27 |
Adamed Pharma S.A |
A process for preparation of tartaric acid cores for dabigatran pellets and the pellets containing dabigatran
|
|
GR1010399B
(el)
*
|
2022-04-05 |
2023-02-03 |
Φαρματεν Α.Β.Ε.Ε., |
Φαρμακευτικο σκευασμα που περιλαμβανει εναν αντιπηκτικο παραγοντα και μεθοδος παραγωγης αυτου
|
|
WO2024175037A1
(zh)
*
|
2023-02-21 |
2024-08-29 |
广州玻思韬控释药业有限公司 |
达比加群酯或其药物可接受的盐的微丸
|
|
WO2024217830A1
(en)
|
2023-03-30 |
2024-10-24 |
Adamed Pharma S.A |
A process for preparation of hard capsules filled with dabigatran pellets
|